Parschauer Karah Herdman Insider Trades & Stock Holdings

EVP and Chief Legal Officer · Ultragenyx Pharmaceutical Inc. · Latest filing Jun 15, 2026

Parschauer Karah Herdman, EVP and Chief Legal Officer at Ultragenyx Pharmaceutical Inc. has 1 Form 4 trade on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($46.75K), net -$46.75K. Latest filing: disposed of 1.90K shares of $RARE on Jun 15, 2026 at $24.62.

Trades on file

1

Open-market bought

$0

Open-market sold

$46.75K

Net open-market

-$46.75K

Latest filing

Jun 15, 2026

All insider trades by Parschauer Karah Herdman

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$RARE	Sell (Open-market sale) 10b5-1	1.90K	$24.62	$46.75K			+14.4%	+24.9%		EVP and Chief Legal Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Parschauer Karah Herdman traded

• $RARE

Frequently asked questions

Has Parschauer Karah Herdman been buying or selling stock?

Parschauer Karah Herdman has 0 open-market purchases and 1 open-market sale on file, net -$46.75K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Parschauer Karah Herdman's latest insider trade?

disposed of 1.90K shares of $RARE on Jun 15, 2026 at $24.62.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.